Jorsal A, Kistorp C, Holmager P et al (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)a multicentre, double-blind, randomised, placebo-controlled trial
JOE ROGAN: Right, right, right
These symptoms may affect nutrient absorption and electrolyte balance, and could also indicate serious complications such as pancreatitis or gallbladder disease
Other semaglutides can have a shorter window of 28 days under the same conditions
GLP-1 receptors are present in various brain regions, including areas involved in learning and memory such as the hippocampus
These medications fundamentally alter pancreatic islet cell function in a glucose-dependent manner, which provides both therapeutic efficacy and an important safety advantage over older diabetes medications